Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HLA-DRA antibody

This anti-HLA-DRA antibody is a Mouse Monoclonal antibody detecting HLA-DRA in FACS, IF and IHC (f). Suitable for Human.
Catalog No. ABIN6937414

Quick Overview for HLA-DRA antibody (ABIN6937414)

Target

See all HLA-DRA Antibodies
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reactivity

  • 119
  • 17
  • 11
  • 9
  • 9
  • 9
  • 9
  • 4
  • 3
  • 2
Human

Host

  • 73
  • 68
  • 4
  • 1
  • 1
Mouse

Clonality

  • 74
  • 73
Monoclonal

Conjugate

  • 88
  • 14
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
This HLA-DRA antibody is un-conjugated

Application

  • 74
  • 63
  • 51
  • 38
  • 33
  • 27
  • 22
  • 21
  • 9
  • 9
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

19-26-1-same as MB-26-1
  • Specificity

    This MAb reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Raji cells

    Isotype

    IgG2a kappa
  • Application Notes

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Raji, Ramos, Daudi or HuT78 cells. Tonsil or lymph node.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Alternative Name

    HLA-DRA

    Background

    DR alpha chain, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, HLA DRA, HLA DRA1, HLA-DRA, HLADRA1, Major histocompatibility complex class II DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA,HLA-DRA (MHC II)
    Cellular localisation: Cell surface

    Molecular Weight

    36kDa (α, chain) and 27kDa (β, chain)

    Gene ID

    3122, 520048

    UniProt

    P01903

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
You are here:
Chat with us!